Newborn screening benefits public health by reducing the incidence of severe disabilities and improving the quality of life for affected individuals. It also lessens the economic burden on healthcare systems by preventing long-term complications associated with untreated metabolic disorders. This proactive approach exemplifies the integration of public health and toxicology in safeguarding future generations.
